FDA Inspection
ITxM Clinical ServicesITxM Clinical Services – FDA Inspection, Mar 23, 2017
Record Details
This FDA Inspection record concerns ITxM Clinical Services, with an inspection on March 23, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · d9ae3139-3859-4289-9919-27ff98fdad0c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1008797
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 606.160(b)Required records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ITxM Clinical Services
2| Date | Classification | Office | Project area |
|---|---|---|---|
| March 30, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 29, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for ITxM Clinical Services
- FDA Inspection 1010228 - 2017-03-30
- FDA Inspection 908695 - 2015-01-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.